LV10391A - The use of alkylphosphorus compounds for the treatment of psoriasis diseases - Google Patents

The use of alkylphosphorus compounds for the treatment of psoriasis diseases

Info

Publication number
LV10391A
LV10391A LV920169A LV920169A LV10391A LV 10391 A LV10391 A LV 10391A LV 920169 A LV920169 A LV 920169A LV 920169 A LV920169 A LV 920169A LV 10391 A LV10391 A LV 10391A
Authority
LV
Latvia
Prior art keywords
alkylphosphorus
compounds
treatment
psoriasis diseases
psoriasis
Prior art date
Application number
LV920169A
Other languages
Latvian (lv)
Other versions
LV10391B (en
Inventor
Hansjoerg Eibl
Clemens Unger
Juergen Engel
Original Assignee
Asta Medica Ag
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6390272&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LV10391(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Asta Medica Ag, Max Planck Gesellschaft filed Critical Asta Medica Ag
Publication of LV10391A publication Critical patent/LV10391A/en
Publication of LV10391B publication Critical patent/LV10391B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/664—Amides of phosphorus acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LVP-92-169A 1989-09-27 1992-10-27 Use of derivatives of alkylphosphoric acid for healing of psoriasis LV10391B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3932183 1989-09-27

Publications (2)

Publication Number Publication Date
LV10391A true LV10391A (en) 1995-02-20
LV10391B LV10391B (en) 1995-10-20

Family

ID=6390272

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-92-169A LV10391B (en) 1989-09-27 1992-10-27 Use of derivatives of alkylphosphoric acid for healing of psoriasis

Country Status (17)

Country Link
EP (2) EP0419998A3 (en)
JP (1) JP3176615B2 (en)
CA (1) CA2026278C (en)
DD (1) DD298052A5 (en)
DE (1) DE4029747C2 (en)
EG (1) EG19338A (en)
FI (1) FI904726A0 (en)
HU (1) HU209589B (en)
IE (1) IE903464A1 (en)
LT (1) LT3804B (en)
LV (1) LV10391B (en)
MC (1) MC2150A1 (en)
NO (1) NO904184L (en)
PT (1) PT95422B (en)
RU (1) RU1837877C (en)
UA (1) UA19335A (en)
ZA (1) ZA907702B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4233044A1 (en) * 1992-10-01 1994-04-07 Asta Medica Ag Phospholipid derivatives that contain higher elements of the 5th main group
US5958906A (en) * 1992-10-01 1999-09-28 Asta-Medica Aktiengesellschaft Phospholipid derivatives containing higher elements of the fifth main group
DE4235911A1 (en) * 1992-10-23 1994-04-28 Asta Medica Ag Stabilized hexadecylphosphocholine solutions in glycerol alkyl ethers
PL189654B1 (en) 1998-01-22 2005-09-30 Zentaris Gmbh Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis
DE102006004821B4 (en) * 2006-01-30 2020-12-10 Cuma Kilic Collection container for waste and building rubble
US8722648B2 (en) 2009-07-09 2014-05-13 Paul Meng Liquid pharmaceutical form of alkylphosphocholine and method for preparing same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761404A (en) * 1985-07-01 1988-08-02 Merck & Co., Inc. Phospholipid analogs useful as PAF synthesis inhibitors
IE59778B1 (en) * 1985-12-04 1994-04-06 Max Planck Gesellschaft Medicament with anti-tumour action containing hexadecylphosphocholine
DE3829899C2 (en) * 1988-09-02 1994-12-15 Reutter Werner Glycerine glycophosphatides and pharmaceutical compositions containing them for combating skin diseases

Also Published As

Publication number Publication date
HU906233D0 (en) 1991-03-28
HUT55992A (en) 1991-07-29
PT95422B (en) 1997-07-31
NO904184L (en) 1991-04-02
UA19335A (en) 1997-12-25
LTIP1488A (en) 1995-06-26
PT95422A (en) 1991-05-22
JP3176615B2 (en) 2001-06-18
EP0916343A1 (en) 1999-05-19
JPH03130228A (en) 1991-06-04
ZA907702B (en) 1991-07-31
LV10391B (en) 1995-10-20
HU209589B (en) 1994-08-29
NO904184D0 (en) 1990-09-26
CA2026278C (en) 1996-04-30
LT3804B (en) 1996-03-25
EP0419998A3 (en) 1991-10-23
IE903464A1 (en) 1991-04-10
EG19338A (en) 1994-12-30
FI904726A0 (en) 1990-09-26
CA2026278A1 (en) 1991-03-28
DE4029747C2 (en) 2003-10-02
EP0419998A2 (en) 1991-04-03
RU1837877C (en) 1993-08-30
DD298052A5 (en) 1992-02-06
MC2150A1 (en) 1992-03-10
DE4029747A1 (en) 1991-04-11

Similar Documents

Publication Publication Date Title
GB2188844B (en) Pharmaceutical composition for the treatment of psoriasis
NO179353C (en) Use of microbicidal compounds of dimethylamine-epichlorohydrinamines
NO924461D0 (en) DIPYRIDAMOL FOR THE TREATMENT OF PROLIFERACTIVE DISEASES
FI945441A (en) New process for the preparation of 7beta-substituted-4-aza-5alpha-androstan-3-ones
IS1667B (en) Analogue method for the preparation of therapeutically active aza-bicyclic compounds
IT1221826B (en) PREPARED FOR TOPICAL USE FOR THE THERAPEUTIC TREATMENT OF IMPOTENTIA COEUNDI
BG94738A (en) USE OF IODINE SOLUTION FOR THE TREATMENT OF IODINE DEFICIENCY DISEASES
AU6142186A (en) Use of melatonin or related compounds for the treatment of psoriasis
US4931457B1 (en) Naphthylamino-and naphthyloxy-pyridineamin compounds useful as topical antiinflammatory agents for the treatment of skin disorders
LV10391A (en) The use of alkylphosphorus compounds for the treatment of psoriasis diseases
NO164899C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE IMIDAZOLYLINDOL COMPOUNDS.
KR930702990A (en) Prostacyclin- and carbacycline derivatives for the treatment of fibrotic diseases
IT1232822B (en) USE OF PROGESTINE FOR THE TREATMENT OF OSTEOPOROSIS
IT8420682A1 (en) "Procedure for the treatment of knitwear"
NO920983L (en) PROCEDURE FOR THE TREATMENT OF NEVRODEGENERATIVE CONDITIONS
DK484186A (en) PROCEDURE FOR THE PREPARATION OF A PREPARATION FOR THE TREATMENT OF PSORIASIS
NO172115C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE BRONCHOSPASMOLYTIC COMPOUNDS
FI91069B (en) Process for the preparation of 5-C-hydroxymethylaldhexose-based compounds
NO173871C (en) Procedure for the preparation of penem compounds
ZA86370B (en) Arylalkoxyphenyl-allylic alcohols as agents for the treatment of hypersensitive ailments
IT8212678A0 (en) PREPARATION FOR THE TREATMENT OF ACNE
IL99236A0 (en) Pharmaceutical composition for the topical treatment of psoriasis
KR890701106A (en) Use of oxoquinazoline derivatives for the treatment of hyperlipidemia
NO920694L (en) PROCEDURE FOR TREATMENT OF TREMASS
IT8419940A0 (en) NEW MEDICINES FOR THE TREATMENT OF HEART DISEASES.